tiprankstipranks
Cyclo Therapeutics (CYTH)
NASDAQ:CYTH
US Market
Holding CYTH?
Track your performance easily

Cyclo Therapeutics (CYTH) Financial Statements

195 Followers

Cyclo Therapeutics Financial Overview

Cyclo Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.895; its P/E ratio is -0.70; Cyclo Therapeutics is scheduled to report earnings on March 17, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 233.77K$ 123.10K$ 202.45K$ 311.40K$ 495.48K
Gross Profit$ 216.97K$ 109.72K$ 202.45K$ 285.71K$ 456.71K
EBIT$ -8.83M$ -5.25M$ -4.34M$ -5.64M$ -4.77M
EBITDA$ -8.83M$ -5.25M$ -4.34M$ -5.64M$ -4.76M
Net Income Common Stockholders$ -8.83M$ -5.25M$ -4.33M$ -5.64M$ -4.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 928.01K$ 1.12M$ 3.00M$ 9.25M$ 1.80M
Total Assets$ 5.25M$ 4.72M$ 7.16M$ 13.25M$ 5.60M
Total Debt$ 12.21M$ 3.00M$ 665.06K$ 1.03M$ 45.23K
Net Debt$ 11.28M$ 1.88M$ -2.33M$ -8.21M$ -1.76M
Total Liabilities$ 18.73M$ 9.84M$ 6.55M$ 8.49M$ 6.65M
Stockholders Equity$ -13.47M$ -5.12M$ 609.76K$ 4.76M$ -1.05M
Cash Flow-
Free Cash Flow$ -8.19M$ -3.85M$ -6.18M$ -4.30M$ -4.04M
Operating Cash Flow$ -8.19M$ -3.85M$ -6.18M$ -4.29M$ -4.04M
Investing Cash Flow---$ -2.42K-
Financing Cash Flow$ 8.00M$ 1.97M$ -69.28K$ 11.74M$ 5.00M
Currency in USD

Cyclo Therapeutics Earnings and Revenue History

Cyclo Therapeutics Debt to Assets

Cyclo Therapeutics Cash Flow

Cyclo Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis